AI assistant
Mankind Pharma Limited — Call Transcript 2026
Feb 3, 2026
61869_rns_2026-02-03_968e4e2c-fd7a-410a-a3d0-11b3cbc13606.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [559 x 53] intentionally omitted <==
==> picture [559 x 55] intentionally omitted <==
February 3, 2026
BSE Limited
P J Towers, Dalal Street, Mumbai – 400 001
Scrip Code: 543904
National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051
Symbol: MANKIND
Dear Sir/ Madam,
Subject: Investor Conference Call for Q3 & 9M FY26 – Audio Recording
Pursuant to Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated January 16, 2026 under subject ‘Intimation of Investor Conference Call for Q3 & 9M FY26 with Senior Management of Mankind Pharma Limited (“the Company”)’ , the audio recording of the Call held today i.e. February 3, 2026 is available on the - - website of the Company at https://www.mankindpharma.com/wp content/uploads/2026/02/Q3FY26 Earnings-Call-Audio.mp3
You are requested to kindly take the same on records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
HITESH Digitally signed by HITESH KUMAR KUMAR JAIN Date: 2026.02.03 JAIN 21:36:32 +05'30' Hitesh Kumar Jain Company Secretary & Compliance Officer
==> picture [557 x 60] intentionally omitted <==